Rhythm Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 60.1M | 57.3M | 51.3M | 48.5M | 32.7M | 41.8M | 33.3M | 29.1M |
| Cost of Goods Sold | 7.2M | 4.8M | 5.5M | 5.5M | 3.6M | 3.8M | 3.8M | 2.9M |
| Gross Profit | 53.0M | 52.5M | 45.8M | 43.0M | 29.1M | 38.0M | 29.4M | 26.1M |
| R&D Expenses | 41.7M | 42.0M | 46.0M | 42.3M | 37.0M | 41.2M | 37.9M | 30.0M |
| Operating Expenses | 105.3M | 99.5M | 98.5M | 88.3M | 76.1M | 79.3M | 73.3M | 66.6M |
| Operating Income | -52.4M | -47.1M | -52.7M | -45.3M | -47.0M | -41.3M | -43.9M | -40.5M |
| Other Income / Gains | -2.7M | -473K | -140K | -999K | -2.4M | -2.1M | -100K | 8.7M |
| Net Income | -55.6M | -47.5M | -52.9M | -46.6M | -49.5M | -43.3M | -43.6M | -32.3M |
| EPS (Diluted) | -0.83 | -0.73 | -0.82 | -0.75 | -0.81 | -0.72 | -0.71 | -0.53 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.881 | 0.916 | 0.893 | 0.886 | 0.888 | 0.909 | 0.885 | 0.899 |
| General And Administrative Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 63.6M | 57.5M | 52.4M | 45.9M | 39.1M | 38.1M | 35.4M | 36.4M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 112.5M | 104.3M | 104.0M | 93.8M | 79.7M | 83.1M | 77.1M | 69.6M |
| Interest Income | 3.6M | 4.1M | 4.3M | 3.2M | 3.6M | 3.5M | 4.1M | 4.1M |
| Interest Expense | 4.6M | 4.6M | 4.7M | 5.8M | 5.4M | 5.4M | 5.2M | 4.6M |
| Depreciation And Amortization | 252K | 272K | 304K | 379K | 383K | 383K | 385K | 390K |
| Ebitda | -52.4M | -42.6M | -47.7M | -40.1M | -43.6M | -37.6M | -38.4M | -26.8M |
| Ebitdaratio | -0.871 | -0.745 | -0.931 | -0.827 | -1.334 | -0.898 | -1.154 | -0.921 |
| Operating Income Ratio | -0.871 | -0.822 | -1.026 | -0.934 | -1.437 | -0.986 | -1.32 | -1.392 |
| Income Before Tax | -55.1M | -47.5M | -52.8M | -46.3M | -49.4M | -43.4M | -44.0M | -31.8M |
| Income Before Tax Ratio | -0.917 | -0.83 | -1.029 | -0.954 | -1.511 | -1.037 | -1.323 | -1.093 |
| Income Tax Expense | 545K | -31K | 111K | 337K | 80K | -90K | -344K | 479K |
| Net Income Ratio | -0.926 | -0.83 | -1.031 | -0.961 | -1.514 | -1.035 | -1.312 | -1.109 |
| Epsdiluted | -0.83 | -0.73 | -0.82 | -0.75 | -0.81 | -0.72 | -0.71 | -0.53 |
| Weighted Average Shs Out | 68.0M | 66.9M | 64.3M | 63.7M | 63.1M | 61.6M | 61.2M | 61.0M |
| Weighted Average Shs Out Dil | 68.0M | 66.9M | 64.3M | 63.7M | 63.1M | 61.6M | 61.2M | 61.0M |